Gapping up
In reaction to strong earnings/guidance:
- EHTH +20.8%, DBX +14.4%, DCO +13.9%, NCMI +12.5%, AERI +12.4%, BAND +10.4%, SFM +8.8%, TXRH +7.6%, ZIXI +7.6%, DE +6.3%, CENX +5.4%, USM +4.4%, GLOB +4.4%, ITT +3.8%, TDS +3.2%, CNNE +2.5%, CATM +2.4%, GLPI +2.1%, SSRM +2.1%, RY +2%, HTGC +1.6%, CFX +1.6%, PRAH +1.4%, WPM +1.4%, CNK +1.3%, CASA +1.1%, VICI +1%, SBAC +1%
M&A news:
- AVX +5.4% (Kyocera to acquire all shares it does not own for $21.75 per share)
- S +2.6% (TMUS and S amend combination agreement)
Other news:
- BMRN +2.1% (announces FDA accepted for Priority Review BLA regarding valoctocogene roxaparvovec)
Analyst comments:
- CLDX +10.1% (initiated with an Overweight at Cantor Fitzgerald)
- CHWY +5.1% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- WW +4.3% (upgraded to Buy from Neutral at DA Davidson)
- AIRG +2.6% (upgraded to Buy from Neutral at B. Riley FBR)
- REAL +2.6% (upgraded to Outperform from Mkt Perform at Raymond James)
- LB +2% (upgraded to Outperform from In-line at Evercore ISI)